Relevant bibliographies by topics / Transplantation of organs, tissues, etc. in children / Dissertations / Theses
To see the other types of publications on this topic, follow the link: Transplantation of organs, tissues, etc. in children.

Dissertations / Theses on the topic 'Transplantation of organs, tissues, etc. in children'

Author: Grafiati
Published: 4 June 2021
Last updated: 28 February 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 dissertations / theses for your research on the topic 'Transplantation of organs, tissues, etc. in children.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse dissertations / theses on a wide variety of disciplines and organise your bibliography correctly.

1

Pummer-Verté, Lila. "Organ donation and transplantation /." Online version of thesis, 1995. http://hdl.handle.net/1850/12252.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Van, den Berg Leon. "Organ and tissue donation and transplantation a perspective of South African Baptists from the Baptist Northern Association and its implications for preaching /." Pretoria : [s.n.], 2006. http://upetd.up.ac.za/thesis/available/etd-10022007-164428/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Chudik, John D. "Human fetal tissue transplantation an Orthodox Christian ethical evaluation /." Theological Research Exchange Network (TREN), 1994. http://www.tren.com.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Fisher, Karen Joan. "Allocating scarce resources an ethical case study of organ transplantation /." Theological Research Exchange Network (TREN), 1997. http://www.tren.com.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Motallebzadeh, Reza. "Tertiary lymphoid organogenesis in solid organ transplantation." Thesis, University of Cambridge, 2013. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.608121.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Greenwood, Gay. "The spaces within : a Foucaudian analysis of organ donation discourses /." Title page, table of contents and abstract only, 1999. http://web4.library.adelaide.edu.au/theses/09PH/09phg81652.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Shubane, Nancy. "Black critical care nurses' perceptions of organ donation and organ transplantation." Pretoria : [s.n.], 2009. http://upetd.up.ac.za/thesis/available/etd-10262009-185326/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Poliachik, Sandra Louise. "Transplant organ preservation cooler." Thesis, Virginia Tech, 1991. http://hdl.handle.net/10919/41591.

Full text
Abstract:
A method for preserving transplant organs for extended periods of time has been developed in the transplant organ preservation cooler. The preservation cooler enhances organ viability by maintaining a temperature controlled organ bath and pumping perfusate through the transplant organ. The emphasis on the transplant organ preservation cooler is to provide a simple and portable system which will be powered by boiled off oxygen from a liquid oxygen source. The design of the preservation cooler pump and temperature control system are presented. Results of tests proving the successful operation of the preservation cooler prototype are also presented.
Master of Science
APA, Harvard, Vancouver, ISO, and other styles
9

Nagel, Markus. "Organtransplantation und Internationales Privatrecht." Berlin ; Heidelberg : Springer, 2009. http://deposit.d-nb.de/cgi-bin/dokserv?id=3182142&prov=M&dok%5Fvar=1&dok%5Fext=htm.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Waln, Donna L. "The ethics of fetal tissue research and transplant." Theological Research Exchange Network (TREN), 1998. http://www.tren.com.

Full text
APA, Harvard, Vancouver, ISO, and other styles
11

Wong, Mei-yi, and 王美兒. "Improving engraftment potential of hMSCs after encapsulation in collagen microsphere: an in vitro and in vivostudy." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2012. http://hub.hku.hk/bib/B47753080.

Full text
Abstract:
Stem cell-based therapies are promising in regenerative medicine. However, the success of cell therapy is greatly limited by the low engraftment rate to the target tissues. The present study demonstrated that human mesenchymal stem cells (hMSCs) were subjected to a self selection process via microencapsulation in collagen barrier when they were induced to migrate out from this barrier. While retaining the immuophenotype and self renewal capacity, the selected hMSCs showed a significantly better in vitro migratory response of than those cultured in traditional monolayer. The migratory response could be controlled by varying the fabrication parameters of the collagen barrier, including initial collagen concentration and cells seeding density. Affinity to adhere on endothelial cells layer is another engraftment related property. Significant difference was observed between these selected hMSCs and hMSCs in monolayer culture. In order to investigate the engraftment potential of the selected hMSCs, an animal model was performed. The selected hMSCs were transplanted intravenously into NOD/SCID mice under partial hepatectomy. Presence of human cells in the residual liver was determined by the presence of human HLA-ABC using flow cytometry after 48 hours, 1 week and 1 month. Engraftment of the selected hMSCs was significantly higher than that of monolayer cultured hMSCs in time point of 1 month. It demonstrated that the selected hMSCs favor the engraftment to the injured liver. Further investigation is required to determine the fate of the engrafted hMSCs in order to truly confirm their therapeutic potential. The current work demonstrated that collagen-hMSCs microsphere could act as a barrier to select hMSCs with enhanced in vitro migratory response and in vivo engraftment properties. These findings may contribute towards the development of better stem cell therapies.
published_or_final_version
Mechanical Engineering
Master
Master of Philosophy
APA, Harvard, Vancouver, ISO, and other styles
12

Tsang, K. "Prioritization preferences for corneal transplantation allocation in Hong Kong." Click to view the E-thesis via HKUTO, 2004. http://sunzi.lib.hku.hk/hkuto/record/B31972226.

Full text
APA, Harvard, Vancouver, ISO, and other styles
13

Pawlowski, Kai. "Die strafrechtliche Bewertung der Organtransplantation /." Bochum : [s.n.], 2007. http://swbplus.bsz-bw.de/bsz267327285inh.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
14

Plata-Muñoz, Juan José. "Clinical, biochemical and molecular markers of injury before transplantation." Thesis, University of Oxford, 2012. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.572681.

Full text
Abstract:
The use of organs from donors after circulatory death (DCD) has been recommended as one strategy to enlarge the donor pool and raise the transplant rate. However, DCD allografts had higher incidence of early post-transplant dysfunction. The general aim of this research project was to develop clinical and experimental strategies to reduce the incidence of early post-transplant dysfunction of kidney and liver allografts from DCD. First the ability of a clinical scoring system based on donor data for identifying DCD kidneys with high-risk of post-transplant dysfunction was evaluated using the Oxford and the UK National DCD kidney transplant cohorts. This works suggest that stratification of DCD kidneys before transplantation might allow early identification of kidneys in which lower graft function and survival could be expected if any additional therapeutic intervention is implemented. Second, as it has been suggested that hypothermic machine perfusion (HMP) may protect DCD kidneys from additional preservation injury and improve their outcome after transplantation, this work explored the benefit of HMP as preservation technique fo DCD kidneys in Oxford and discusses the potential of this technique for reducing the incidence of post-transplant dysfunction in DCD kidneys. The Oxford. Liver Group has provided evidence of the benefit of preservation with normothermic machine perfusion (NMP) on post-transplant function and survival of DCD liver allografts. In this work, the molecular mechanisms associated with this benefit were characterized using micro array technology. This analysis suggests that the beneficial effect ofNMP may be associated with the induction of the ischaemic preconditioning phenomenon and highlights a group of genes with potential for gene therapy. Finally, this works provides the "proof-of-concept" that the use of a non-mammalian viral vector for gene transfer of kidneys and livers during conventional cold preservation is feasible and is not associated with additional tissue injury.
APA, Harvard, Vancouver, ISO, and other styles
15

Dare, Anna Jane. "Targeting mitochondria during ischaemia-reperfusion injury in organ transplantation." Thesis, University of Cambridge, 2014. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.708069.

Full text
APA, Harvard, Vancouver, ISO, and other styles
16

Waring, Duff William Ramus. "Medical benefit and the human lottery an egalitarian approach to patient selection /." Dordrecht ; Norwell, Mass. : Springer, 2004. http://site.ebrary.com/id/10221758.

Full text
APA, Harvard, Vancouver, ISO, and other styles
17

Staatz, Christine Elizabeth. "Population pharmacokinetics of tacrolimus with pharmacodynamic exploration in different organ transplant groups /." St. Lucia, Qld, 2001. http://www.library.uq.edu.au/pdfserve.php?image=thesisabs/absthe16521.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
18

Zheng, Ling 1958. "Airway inflammation and remodelling post human lung transplantation." Monash University, Dept. of Medicine, 2002. http://arrow.monash.edu.au/hdl/1959.1/8099.

Full text
APA, Harvard, Vancouver, ISO, and other styles
19

Wong, Hoi-ling, and 王凱玲. "Migration and other characteristics of collagen microencapsulated hMSCs: a comparison with hMSCs intraditional 2D culture." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2008. http://hub.hku.hk/bib/B4150902X.

Full text
APA, Harvard, Vancouver, ISO, and other styles
20

Summers, Dominic Mark. "Maximising the potential for kidney donation in the UK : the role of donation after circulatory-death." Thesis, University of Cambridge, 2013. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.645969.

Full text
APA, Harvard, Vancouver, ISO, and other styles
21

Wong, Hoi-ling. "Migration and other characteristics of collagen microencapsulated hMSCs a comparison with hMSCs in traditional 2D culture /." Click to view the E-thesis via HKUTO, 2008. http://sunzi.lib.hku.hk/hkuto/record/B4150902X.

Full text
APA, Harvard, Vancouver, ISO, and other styles
22

Tziampazis, Evangelos. "Engineering functional, insulin-secreting cell systems : effect of entrapment on cellular environment and secretory response." Thesis, Georgia Institute of Technology, 1993. http://hdl.handle.net/1853/10026.

Full text
APA, Harvard, Vancouver, ISO, and other styles
23

Cabaniss, Thomas Ervin. "The pastor's ministry to people facing organ transplantation." Online full text .pdf document, available to Fuller patrons only, 2001. http://www.tren.com.

Full text
APA, Harvard, Vancouver, ISO, and other styles
24

Robertson-Malt, Suzie. "Life or death : a donor parent's dilemma /." Title page, contents and abstract only, 1998. http://web4.library.adelaide.edu.au/theses/09PH/09phr6524.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
25

Li, Xianliang, and 李先亮. "Insulin in UW solution exacerbates the ischemia/reperfusion injury in rat liver transplantation." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2003. http://hub.hku.hk/bib/B27785257.

Full text
APA, Harvard, Vancouver, ISO, and other styles
26

Dansirikul, Chantaratsamon. "Pharmacokinetic studies with sirolimus and tacrolimus /." [St. Lucia, Qld.], 2004. http://www.library.uq.edu.au/pdfserve.php?image=thesisabs/absthe18266.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
27

楊振帆 and Zhenfan Yang. "Recombinant adeno-associated virus vector as a novel vehicle organ transplantation and long-term allograft survival induced by rAAV-hCTLA4Ig gene transfer combined with low-dose FK506." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2002. http://hub.hku.hk/bib/B31243861.

Full text
APA, Harvard, Vancouver, ISO, and other styles
28

Higginbotham, Bradley Y. Beard T. Randolph. "An examination of the impact of the Organ Donation Breakthrough Collaborative on kidney transplant activity." Auburn, Ala, 2009. http://hdl.handle.net/10415/1738.

Full text
APA, Harvard, Vancouver, ISO, and other styles
29

Kozak, Allyson Jill. "The balance of nitric oxide and peroxynitrite in the heart during organ preservation." View abstract, 2007. http://gateway.proquest.com/openurl?url_ver=Z39.88-2004&res_dat=xri:pqdiss&rft_val_fmt=info:ofi/fmt:kev:mtx:dissertation&rft_dat=xri:pqdiss:3295438.

Full text
APA, Harvard, Vancouver, ISO, and other styles
30

Yang, Zhenfan. "Recombinant adeno-associated virus vector as a novel vehicle organ transplantation and long-term allograft survival induced by rAAV-hCTLA4Ig gene transfer combined with low-dose FK506 /." Hong Kong : University of Hong Kong, 2002. http://sunzi.lib.hku.hk/hkuto/record.jsp?B25085530.

Full text
APA, Harvard, Vancouver, ISO, and other styles
31

Bedaiwy, Mohamed Ali. "Ovarian tissue cryopreservation and transplantation : approaches and techniques /." Cleveland, Ohio : Cleveland Clinic, 2007. http://www.loc.gov/catdir/toc/ecip082/2007042633.html.

Full text
APA, Harvard, Vancouver, ISO, and other styles
32

Nikkhah, Guido. "Microtransplantation of nigral dopamine neurons in a rat model of Parkinson's disease studies on functional recovery and structural repair in adult and neonatal rats with lesions of the mesotelencephalic dopamine system /." Lund : Dept. of Medical Cell Research, Lund University, 1994. http://catalog.hathitrust.org/api/volumes/oclc/39693821.html.

Full text
APA, Harvard, Vancouver, ISO, and other styles
33

McGregor, Lesley M. "An investigation into the functional and psychosocial impact of living organ donation." Thesis, University of Stirling, 2010. http://hdl.handle.net/1893/2338.

Full text
Abstract:
General Abstract Objective: In April 2006, the Scottish Liver Transplant Unit (SLTU) became the first NHS transplant unit in the UK to offer the option of Living Donor Liver Transplantation (LDLT). This represented a unique opportunity to evaluate the functional and psychosocial impact of LDLT upon healthy donors and their recipients. Subsequent aims were to investigate the challenge of introducing LDLT in Scotland and to establish the perceived deterrents and attractions of the procedure. An additional aim was to evaluate the impact of Living Donor Kidney Transplantation (LDKT) upon donors and recipients. Design: A series of cross sectional and longitudinal studies were designed for the purpose of this thesis (3 quantitative, 2 qualitative, and 1 mixed methods). Method: Self report questionnaires were used in each of the quantitative studies, with the addition of neuropsychological computerized tests in two studies. Semi-structured interviews were employed in the qualitative studies. Main Findings: •Prior to its introduction general support for the option of LDLT was found, although it was highlighted that the risk involved was not well understood by the general public. •Since becoming available LDLT has not been a readily acceptable treatment option from the perspective of patients due to the perceived risk for the donor, but it may be considered as a “last option”. Family members were motivated to save their loved one’s life but the personal implications of donating resulted in reconsideration of LDLT. • Staff at the SLTU perceived a lack of family commitment in relation to LDLT, which is explained as a cultural factor contributing to the slow uptake of LDLT. In Scotland, a donation from a younger to an older generation is not easily accepted. This, in addition to patients’ optimism that a deceased donation will arrive, and the poor health of potential donors, is thought to have affected the uptake of LDLT. As has the unit’s conservative approach to the promotion of LDLT. This approach is the result of a perceived reduction in the need for LDLT and a preference to avoid the risk to a healthy donor and conduct transplants with deceased donations. • In over 3 years, only one couple completed LDLT. The recipient showed functional and psychosocial improvement from pre to post procedure, whilst the donor showed slight deterioration in aspects of quality of life 6 weeks post donation, which did not always completely return to a baseline level by 6 months. The donor made sacrifices to provide her husband with a fresh start to life and unmet expectations were found to effect quality of life. •Willingness to become a liver donor is not thought to be influenced by the frame of the information provided. •Like the LDLT donor, LDKT donors experience some functional and psychosocial deterioration at 6 weeks post donation, but donors largely recover by 6 months post donation. However, the anticipated benefit to recipients was not evident and may not be quantifiable until after 6 months post operation. Conclusion: This thesis has added to current knowledge on living organ donation and specifically represents the first psychological evaluation of a UK LDLT programme. The slow uptake of LDLT was unexpected and has resulted in informative, novel research.
APA, Harvard, Vancouver, ISO, and other styles
34

Moalimishak, Mohamed Rashad. "[The] ethical evaluation of brain dead persons and organ transplantation in contemporary Muslim ethics." Thesis, McGill University, 2008. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=105427.

Full text
Abstract:
This dissertation is primarily about the ethical evaluation ofbrain death, brain-dead persons and organ transplantation in contemporary Muslim ethics.
Cette tQese est premierement au sujet de l'évaluation éthique de la mort cérébrale et les personnes dans un coma dépassé aux éthiques Musulmanes contemporaines.
APA, Harvard, Vancouver, ISO, and other styles
35

Lexis, Louise A. "Cyclosporine A induced alterations to endothelial function and erythrocyte and plasma redox balande, and the benefits of antioxidant supplementation /." [St. Lucia, Qld.], 2005. http://www.library.uq.edu.au/pdfserve.php?image=thesisabs/absthe18605.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
36

Akhtar, Mohammed Zeeshan. "Improving the outcomes of kidney transplantation from deceased organ donors." Thesis, University of Oxford, 2016. https://ora.ox.ac.uk/objects/uuid:cd7c49f5-e5ce-415b-bdcb-7b59197bc1d0.

Full text
Abstract:
This thesis sought to improve our understanding of how kidneys become injured as a consequence of organ donation, with the aim of improving the outcomes of transplantation. Every year, hundreds of patients on the waiting list die whilst awaiting a kidney transplant. With an ever-increasing demand for suitable organs, supply cannot keep up with the pressures on the transplant waiting list. As a consequence the transplant community are forced to use organs that previously would not have been considered suitable for transplant, including from older donors with additional comorbidities. This thesis aimed to develop an understanding as to how the kidney becomes injured during the donation process, identifying which key cellular homeostatic processes are disturbed as a consequence of donation. The thesis outlines the experimental development of rodent models of organ donation replicating the donation process for donation after brain death (DBD) and donation after circulatory death (DCD) donors and also the development of a kidney ischaemia reperfusion injury (IRI) model. Proteomics was subsequently used to identifying global protein alterations in the kidney as a consequence of brain death and ischemia reperfusion injury using bioinformatics tools to identify involvement of cellular pathways. The results indicated alterations in mitochondrial function and metabolic homeostasis occurring following brain death. Alterations in cellular metabolism and mitochondrial function were then confirmed using metabolomics and mitochondrial functional assays. I subsequently evaluated how alterations in cellular hypoxia and the hypoxia inducible factor system is altered in the brain dead organ donor kidney and aimed to target this system as a means of conditioning the brain dead organ donor to prevent mitochondrial and metabolic mediated injury to kidney cells following brain death. This involved exploring the role of prolyl hydroxylase inhibitors, including dimethyloxalylglycine, on mitochondrial function and whether this could be a therapeutic target in organ donation. This thesis provides important insights into the mechanism of injury of kidneys following brain death, providing evidence that even before procurement and preservation in the DBD donor alterations in mitochondrial function and metabolic homeostasis occur. I provide preliminary data on the use of prolyl hydroxylase inhibitors in altering mitochondrial function. I also outline my involvement in other ongoing projects in organ donation and machine perfusion that also aim to improve the outcomes of deceased donor kidney and liver transplantation.
APA, Harvard, Vancouver, ISO, and other styles
37

Dugan, Aisling Siobhan. "The interactions between BK virus and host cell receptors." View abstract/electronic edition; access limited to Brown University users, 2008. http://gateway.proquest.com/openurl?url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:dissertation&res_dat=xri:pqdiss&rft_dat=xri:pqdiss:3318311.

Full text
APA, Harvard, Vancouver, ISO, and other styles
38

Chan, Chun-wai, and 陳春慧. "In-vitro study of the cryopreserved intervertebral disc." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2008. http://hub.hku.hk/bib/B41290380.

Full text
APA, Harvard, Vancouver, ISO, and other styles
39

Bester, Dreyer. "A study of the effects of warm ischaemic times on harvested homografts." Thesis, Bloemfontein : Central University of Technology, Free State, 2009. http://hdl.handle.net/11462/48.

Full text
APA, Harvard, Vancouver, ISO, and other styles
40

Crouch, Robert Alan. "The child as tissue and organ donor." Thesis, McGill University, 1996. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=23714.

Full text
Abstract:
This thesis attempts to answer the following question: Is it ever morally permissible to use a minor child as a tissue or organ donor for the benefit of a family member? Those sceptical of using minors as tissue or organ donors for the benefit of a sick family member will highlight two points: the donor will be subject to risks that are not counterbalanced by possible medical benefits, and the minor cannot consent to the procedure herself.
This thesis will present a review of the medical risks associated with bone marrow and kidney donations, as well as a review of the common law dealing with donations by minors and incompetent persons. The final chapter then makes a case for the permissibility of minor donation based on the interests of the family.
APA, Harvard, Vancouver, ISO, and other styles
41

Tsang, K., and 曾光. "Prioritization preferences for corneal transplantation allocation in Hong Kong." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2004. http://hub.hku.hk/bib/B31972226.

Full text
APA, Harvard, Vancouver, ISO, and other styles
42

Talbert, Robert John. "Photoacoustic discrimination of viable and thermally coagulated blood for burn injury imaging." Diss., Columbia, Mo. : University of Missouri-Columbia, 2007. http://hdl.handle.net/10355/5081.

Full text
Abstract:
Thesis (M.S.)--University of Missouri-Columbia, 2007.
The entire dissertation/thesis text is included in the research.pdf file; the official abstract appears in the short.pdf file (which also appears in the research.pdf); a non-technical general description, or public abstract, appears in the public.pdf file. Title from title screen of research.pdf file (viewed on January 11, 2008) Includes bibliographical references.
APA, Harvard, Vancouver, ISO, and other styles
43

Barbieri, Karina Pereira. "Síntese e avaliação farmacológica de pró-fármacos derivados do ácido micofenólico úteis na prevenção e no tratamento da rejeição de transplantes /." Araraquara, 2014. http://hdl.handle.net/11449/134139.

Full text
Abstract:
Orientador: Jean Leandro dos Santos
Banca: Chung Man Chin
Banca: Cintia Duarte de Freitas Milagre
Resumo: Uma das aplicações da terapia imunossupressora é evitar que ocorra rejeição em situações de transplante de órgãos e auxiliar na sobrevida dos indivíduos. O ácido micofenólico (A.M.) é um imunossupressor de caráter anti-proliferativo, inibidor da inosina 5-monofosfato desidrogenase, porém, apresenta baixa biodisponibilidade oral e por isso na terapêutica utiliza-se o seu pró-fármaco: micofenolato de mofetila. Este trabalho teve como objetivo a síntese de pró-fármacos mútuos do ácido micofenólico ligados a derivados ftalimídicos a fim de garantir-lhe melhorias farmacocinéticas e farmacodinâmicas. Os derivados ftalimídicos encontrados na estrutura de compostos, por exemplo, na talidomida, utilizada em doenças auto-imunes, agem como imunossupressores por inibição de citocinas pró-inflamatórias. Os pró-fármacos foram obtidos com rendimentos que variaram entre 40-53%. As novas moléculas foram caracterizadas utilizando métodos analíticos como ressonância magnética nuclear (RMN), espectrometria na região de infravermelho e espectrometria de massas. Além disso, o coeficiente de partição (log P) foi determinado pelo método de HPLC e usando os programas de Chem Draw® Ultra e AlogPS®.O log P experimental dos derivados apresentou valores entre 2,29 e 4,09. Avaliou-se a citotoxicidade, liberação óxido nítrico (NO) e de citocinas (IL-1β e TNF-α) usando linhagens celulares de macrófagos murinos. A genotoxicidade in vivo foi avaliada usando o teste de micronúcleo. Todos os compostos apresentaram viabilidade celular superior a 70% nas concentrações usadas. O pró-fármaco (E)-2-(1,3-dioxoisoindolin-2-il) etil6-(4-hidroxi-6-metóxi-7-metil-3-oxo-1,3-dihidroisobenzofuran-5-il)-4-metilhex-4-enoato (3a) apresentou valores de IC50 de 200 μM. Na avaliação da inibição de TNF-α todos os pró-fármacos apresentam atividade nas concentrações utilizadas...
Abstract: One of the applications is immunosuppressive therapy to prevent rejection occurs in situations of organ transplantation and assist in the survival of individuals. Mycophenolic acid (MA) is an immunosuppressive anti -proliferative character inhibitor of inosine 5 -monophosphate dehydrogenase but has a low oral bioavailability and therefore therapeutic uses is the prodrug thereof: mycophenolate mofetil. This work aimed at the synthesis of mutual prodrugs of mycophenolic acid derivatives linked to ftalimidic to ensure you Pharmacokinetic and pharmacodynamic improvements. The ftalimdic derived from compounds found in the structure, for example in thalidomide used in autoimmune diseases, they act as immunosuppressants by inhibiting pro-inflammatory cytokines. The prodrugs were obtained with yields ranging from 40-53 %. The new molecules were characterized using analytical methods such as nuclear magnetic resonance (NMR) spectroscopy in the infrared region and mass spectrometry. In addition, the partition coefficient (log P) was determined by HPLC method using programs Chem Draw Ultra ® and AlogPS ®. Experimental log P of the derivatives showed values between 2.29 and 4.09. Cytotoxicity was assessed, the release nitric oxide (NO) and cytokines (IL- 1β and TNF- α) using murine macrophage cell lines. The in vivo genotoxicity was assessed using the micronucleus test. All compounds showed cell viability above 70 % in the concentrations used. The prodrug (E) -2 - (1,3- dioxoisoindolin -2- yl) etil 6 -(4 -hydroxy- 6-methoxy -7-methyl -3-oxo -1,3- dihydroisobenzofuran -5- yl) 4- methylhex -4- enoate ( 3a ) showed IC50 values of 200 mM . In evaluating the inhibition of TNF- α all prodrugs exhibit activity at the concentrations used were the most active, and 3a (E) - (1,3- dioxoisoindolin -2- yl) methyl 6 - (4 -hydroxy -6- methoxy -7-methyl -3-oxo -1,3- dihydroisobenzofuran -5-yl )-4 -methylhex- 4-enoate (3c) with IC50 values of 18.75 mM . In ...
Mestre
APA, Harvard, Vancouver, ISO, and other styles
44

Barbieri, Karina Pereira [UNESP]. "Síntese e avaliação farmacológica de pró-fármacos derivados do ácido micofenólico úteis na prevenção e no tratamento da rejeição de transplantes." Universidade Estadual Paulista (UNESP), 2014. http://hdl.handle.net/11449/134139.

Full text
Abstract:
Made available in DSpace on 2016-02-05T18:29:55Z (GMT). No. of bitstreams: 0 Previous issue date: 2014-06-11. Added 1 bitstream(s) on 2016-02-05T18:33:59Z : No. of bitstreams: 1 000854046.pdf: 1970431 bytes, checksum: a29a47eeb44d6d6a90258f9d36ebbdf4 (MD5)
Uma das aplicações da terapia imunossupressora é evitar que ocorra rejeição em situações de transplante de órgãos e auxiliar na sobrevida dos indivíduos. O ácido micofenólico (A.M.) é um imunossupressor de caráter anti-proliferativo, inibidor da inosina 5-monofosfato desidrogenase, porém, apresenta baixa biodisponibilidade oral e por isso na terapêutica utiliza-se o seu pró-fármaco: micofenolato de mofetila. Este trabalho teve como objetivo a síntese de pró-fármacos mútuos do ácido micofenólico ligados a derivados ftalimídicos a fim de garantir-lhe melhorias farmacocinéticas e farmacodinâmicas. Os derivados ftalimídicos encontrados na estrutura de compostos, por exemplo, na talidomida, utilizada em doenças auto-imunes, agem como imunossupressores por inibição de citocinas pró-inflamatórias. Os pró-fármacos foram obtidos com rendimentos que variaram entre 40-53%. As novas moléculas foram caracterizadas utilizando métodos analíticos como ressonância magnética nuclear (RMN), espectrometria na região de infravermelho e espectrometria de massas. Além disso, o coeficiente de partição (log P) foi determinado pelo método de HPLC e usando os programas de Chem Draw® Ultra e AlogPS®.O log P experimental dos derivados apresentou valores entre 2,29 e 4,09. Avaliou-se a citotoxicidade, liberação óxido nítrico (NO) e de citocinas (IL-1β e TNF-α) usando linhagens celulares de macrófagos murinos. A genotoxicidade in vivo foi avaliada usando o teste de micronúcleo. Todos os compostos apresentaram viabilidade celular superior a 70% nas concentrações usadas. O pró-fármaco (E)-2-(1,3-dioxoisoindolin-2-il) etil6-(4-hidroxi-6-metóxi-7-metil-3-oxo-1,3-dihidroisobenzofuran-5-il)-4-metilhex-4-enoato (3a) apresentou valores de IC50 de 200 μM. Na avaliação da inibição de TNF-α todos os pró-fármacos apresentam atividade nas concentrações utilizadas...
One of the applications is immunosuppressive therapy to prevent rejection occurs in situations of organ transplantation and assist in the survival of individuals. Mycophenolic acid (MA) is an immunosuppressive anti -proliferative character inhibitor of inosine 5 -monophosphate dehydrogenase but has a low oral bioavailability and therefore therapeutic uses is the prodrug thereof: mycophenolate mofetil. This work aimed at the synthesis of mutual prodrugs of mycophenolic acid derivatives linked to ftalimidic to ensure you Pharmacokinetic and pharmacodynamic improvements. The ftalimdic derived from compounds found in the structure, for example in thalidomide used in autoimmune diseases, they act as immunosuppressants by inhibiting pro-inflammatory cytokines. The prodrugs were obtained with yields ranging from 40-53 %. The new molecules were characterized using analytical methods such as nuclear magnetic resonance (NMR) spectroscopy in the infrared region and mass spectrometry. In addition, the partition coefficient (log P) was determined by HPLC method using programs Chem Draw Ultra ® and AlogPS ®. Experimental log P of the derivatives showed values between 2.29 and 4.09. Cytotoxicity was assessed, the release nitric oxide (NO) and cytokines (IL- 1β and TNF- α) using murine macrophage cell lines. The in vivo genotoxicity was assessed using the micronucleus test. All compounds showed cell viability above 70 % in the concentrations used. The prodrug (E) -2 - (1,3- dioxoisoindolin -2- yl) etil 6 -(4 -hydroxy- 6-methoxy -7-methyl -3-oxo -1,3- dihydroisobenzofuran -5- yl) 4- methylhex -4- enoate ( 3a ) showed IC50 values of 200 mM . In evaluating the inhibition of TNF- α all prodrugs exhibit activity at the concentrations used were the most active, and 3a (E) - (1,3- dioxoisoindolin -2- yl) methyl 6 - (4 -hydroxy -6- methoxy -7-methyl -3-oxo -1,3- dihydroisobenzofuran -5-yl )-4 -methylhex- 4-enoate (3c) with IC50 values of 18.75 mM . In ...
APA, Harvard, Vancouver, ISO, and other styles
45

Cohen, Elizabeth Leigh. ""My Loss is Your Gain": Examining the Role of Message Frame, Perceived Risk, and Ambivalence in the Decision to Become an Organ Donor." unrestricted, 2007. http://etd.gsu.edu/theses/available/etd-08062007-011153/.

Full text
Abstract:
Thesis (M.A.)--Georgia State University, 2007.
Title from file title page. Cynthia Hoffner, committee chair; Yuki Fujioka, Holley Wilkin, committee members. Electronic text ( 81 p.) : digital, PDF file. Description based on contents viewed Nov. 8, 2007. Includes bibliographical references (p. 57-65).
APA, Harvard, Vancouver, ISO, and other styles
46

Costa, Dacio Carvalho. "Uso de triancinologia subconjuntival no tratamento da rejeição endotelial do transplante de cornea." [s.n.], 2009. http://repositorio.unicamp.br/jspui/handle/REPOSIP/311490.

Full text
Abstract:
Orientador: Newton Kara-Jose
Tese (doutorado) - Universidade Estadual de Campinas, Faculdade de Ciencias Medicas
Made available in DSpace on 2018-08-13T21:12:46Z (GMT). No. of bitstreams: 1 Costa_DacioCarvalho_D.pdf: 11382661 bytes, checksum: a5c3e2c591c002085753bfe5397e34f3 (MD5) Previous issue date: 2009
Resumo: Objetivo: Comparar a eficácia da injeção subconjuntival de 20 mg de triancinolona associada a prednisolona 1% tópica com a injeção intravenosa de 500 mg de metilprednisolona associada a prednisolona 1% tópica no tratamento da rejeição endotelial de transplante de córnea. Métodos: Estudo caso-controle realizado no Hospital das Clínicas da UNICAMP. Os pacientes submetidos a transplante penetrante de córnea que apresentaram primeiro episódio de rejeição endotelial com até 15 dias do início dos sintomas durante o período de novembro de 2005 a outubro de 2006 foram tratados com injeção subconjuntival de 20 mg de acetonido de triancinolona associado a acetato de prednisolona 1% tópico. Estes pacientes foram pareados por idade e diagnóstico com pacientes submetidos a tratamento com injeção intravenosa de 500 mg de succinato sódico de metilprednisolona associado a acetato de prednisolona 1% tópico e analisados quanto à capacidade de reversão do episódio de rejeição, pressão intraocular aos 30 dias e acuidade visual ao final de 1 ano. Resultados: 16 pacientes foram tratados com 20 mg de triancinolona subconjuntival e prednisolona 1% tópica durante o período de recrutamento e foram pareados com 16 pacientes tratados com 500 mg de metilprednisolona intravenosa e prednisolona 1% tópica. Ao final de 1 ano, o grupo tratado com triancinolona obteve melhores resultados do que o grupo tratado com metilprednisolona (p=0,025), obtendo 15 pacientes com córnea transparente enquanto o grupo tratado com metilprednisolona obteve 10 pacientes. 3 pacientes do grupo tratado com triancinolona apresentaram segundo episódio de rejeição durante o seguimento e foram retratados com sucesso enquanto no grupo da metilprednisolona, 4 pacientes apresentaram segunda rejeição, com 2 pacientes apresentando falência com o retratamento e 2 obtendo sucesso. A pressão intraocular subiu nos dois grupos (p=0,002) após 30 dias, porém não houve diferença entre os grupos (p=0,433). A acuidade visual melhorou após 1 ano em ambos os grupos (p=0,049) e o grupo tratado com triancinolona obteve melhor acuidade visual (p=0,002). Conclusão: A injeção subconjuntival de 20 mg de triancinolona combinada com prednisolona 1% tópica mostrou-se mais eficaz em reverter episódios de rejeição de transplante de córnea neste estudo caso-controle do que a aplicação intravenosa de 500 mg de metilprednisolona. Estudos adicionais necessitam ser realizados para verificar a segurança e eficácia deste tratamento em grandes populações
Abstract: Purpose: To compare the efficacy of 20 mg subconjunctival triamcinolone in association with topical prednisolone 1% to 500 mg intravenous methylprednisolone in association with topical prednisolone 1% in the treatment of cornea endothelial graft rejection. Methods: Case-control study carried out at State University of Campinas Hospital. Patients submitted to penetrating keratoplasty that presented first episode of corneal endothelial rejection within 15 days of symptoms onset between November 2005 and October 2006 were treated with 20 mg subconjunctival injection of triamcinolone acetate in association with topical prednisolone acetate 1%. These patients were matched for age and diagnosis to patients that were submitted to a single 500 mg intravenous injection of methylprednisolone sodium succinate in association with topical prednisolone acetate 1% and analyzed regarding the reversion of the rejection episode, intraocular pressure at day 30 and visual acuity at the end of 1 year. Results: 16 patients were treated with 20 mg subconjunctival triamcinolone and topical prednisolone 1% during the period of recruitment and were matched to 16 patients treated with 500 mg intravenous methylprednisolone and topical prednisolone 1%. At the end of 1 year, the group treated with triamcinolone had a better outcome than the group treated with methylprednisolone (p=0.025), having 15 patients with clear grafts as the group treated with methylprednisolone had 10 patients. 3 patients from the group treated with triamcinolone had new rejection episodes during follow-up and were retreated successfully as in the group treated with methylprednisolone 4 patients had a new rejection episode, with 2 progressing to failure and 2 to success with retreatment. Intraocular pressure rose in both groups (p=0.002) at day 30 but there were no statistically significant differences between the groups (p=0.433). Visual acuity improved after 1 year in both groups (p=0.049) and the group treated with triamcinolone had better visual acuities (p=0.002). Conclusions: 20 mg subconjunctival injection of triamcinolone acetonide associated with topical prednisolone acetate 1% showed to be more effective than 500 mg intravenous methylprednisolone associated with prednisolone acetate 1% in this case-control study. Further studies need to be accomplished to verify its safety and effectiveness in larger populations
Doutorado
Oftalmologia
Doutor em Ciências Médicas
APA, Harvard, Vancouver, ISO, and other styles
47

Campbell, Kenneth. "Internal organization and functional regulation of intrastriatal striatal transplants a study using in situ hybridization histochemistry and intracerebral microdialysis in the excitotoxically lesioned and grafted rat striatum /." Lund : Department of Medical Cell Research, Lund University, 1994. http://books.google.com/books?id=j-tqAAAAMAAJ.

Full text
APA, Harvard, Vancouver, ISO, and other styles
48

Surquin, Murielle. "Role of Th2 cytokines and polymorphonuclear cells in allograft rejection in mice." Doctoral thesis, Universite Libre de Bruxelles, 2007. http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/210627.

Full text
Abstract:
Acute allograft rejection remains a major problem in solid organ transplantation, because rejection may lead to acute or chronic loss of graft function. The failure of certain anti-rejection prophylactic treatments suggests that several unexpected pathways might be involved in the rejection process.

The aim of our experiments was to investigate the effector mechanisms responsible for skin graft rejection in mice. To adress this question, we took advantage of the possibility to restrict the alloimmune response to isolated allogeneic MHC class II molecules or to isolated minor transplantation antigens, combined with the possibility to study separately the response of CD4+ or CD8+ T cells in mice deficient for Th1 or Th2 cytokines or cytotoxic molecules. We used the bm12 skin graft combination (C57BL/6 H2Kbm12 grafted on C57BL/6 H2Kb) as a model of single MHC class II disparity and the b2microglobulin skin graft model (C57BL/6 b2m+/+ grafted on C57BL/6 b2m-/-) as a model of minor transplantation antigen disparity. Our goal was to engage a limited number of effectors, trying in a second time to block each rejection pathway selectively.

We showed that Fas/FasL-mediated CD4+ T cells cytotoxicity, eosinophil recruitment, activation and degranulation induced by Th2 derived cytokines, and CD4-derived IFN-g production are involved in the rejection of grafts bearing either a single MHC class II disparity or b2m-derived minor histocompatibilty antigens. In addition, rejection of MHC class II disparate skin grafts also includes the participation of neutrophils, in particular conditions where the occurrence of the Th2/eosinophil pathway was prevented.

Altogether, our data show a multiplicity and a redundancy of the effector pathways participating in allograft rejection. Among the different effectors pathways identified, including effectors from both innate and adaptive immune systems, some act synergistically, whereas others act as alternative pathways, depending of the degree of donor-recipient mismatch.
Doctorat en Sciences médicales
info:eu-repo/semantics/nonPublished

APA, Harvard, Vancouver, ISO, and other styles
49

O'Driscoll, Catherine T. "A study to determine the quality of life and experiences for liver and kidney transplant recipients and living kidney donors in Western Australia : the economic implications." University of Western Australia. School of Surgery, 2008. http://theses.library.uwa.edu.au/adt-WU2009.0077.

Full text
Abstract:
The use of quality-of-life as an outcome measure provides detailed information about the effectiveness of medical treatments than morbidity or mortality rates alone. The use of quality-of-life data in the clinical setting can inform patients regarding treatment options, treatment benefits and costs. In competing health care markets, outcome measurement is regarded as important as it is concerned with the impact of health care practice and affects health policy decisions. Doessel (1978) conducted the first Australian study on the cost-effectiveness analysis of renal replacement therapies. The study was based on Klarman, Francis & Rosenthal's (1968) the study, where the output was measured in terms of the number of life years gained from kidney transplantation, and a twenty-five percent weight was allocated in an attempt to capture quality-of-life from kidney transplantation. Doessel (1978) used two sources of data: Australian data (Disney 1974) and European data (Gurland et al. 1973; Shiel et al. 1974). The study measured life years gained, and agreed with the Klarman et al. (1974) findings that transplantation is the most effective way to increase life expectancy of persons with chronic renal disease (Butler & Doessel 1989). The outputs of the alternative treatments were not reported in monetary terms; the study focused on life years gained as the output measure. Hence the importance of this current study, which includes a cost-effectiveness analysis for cadaver liver, and living kidney transplantation for end-stage liver and kidney disease patients. Calls to respect patient autonomy and to produce patient-centered outcomes have recently brought the patient’s point of view back into the center of clinical medicine (Sullivan 2003). Survival rates indicate one measure of outcome however they do not reflect patients’ perceptions of health benefit or experiences. Noting that patients’ psychosocial effect on functioning is of more concern to them than their physical Thesis Preamble iii ability, that more accurate knowledge of patients’ conditions be measured prior to transplantation (Tarter et al. 1991). Recently researchers advocated investigating transplant patients' states of health to assess the social benefit of these expensive health care services from their perspective (Joralemon & Fujinaga 1997). The current study's mixed method, bridges the gaps in treatment outcome measurements, as the mixed method applied (Creswell 1994; Sim & Sharp 1998) prospectively measured quality-oflife, determined health utility, quality-adjusted life years (QALYs) and incremental cost-effectiveness ratios (ICERs). The study reported the living donors experience of the donation process, described their needs; expressed using a new psychosocial model supporting future living kidney donor's during the donation process.
APA, Harvard, Vancouver, ISO, and other styles
50

Poulin, Lionel. "Rôles de l'IL-9 dans les mécanismes de rejet d'allogreffe dirigés par les lymphocytes TCDA+ de type Th2." Doctoral thesis, Universite Libre de Bruxelles, 2005. http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/211038.

Full text
Abstract:
Le rejet d’allogreffe dépend de la reconnaissance d’antigènes d’histocompatibilité étrangers par le système immunitaire du receveur. En l'absence de thérapies immunosuppressives, la réaction inflammatoire éventuelle conduit à la destruction rapide du tissu transplanté. Le rôle critique joué par les lymphocytes T CD4+ dans le rejet aigu d'allogreffe est bien établi. Cependant, les contributions respectives des lymphocytes CD4+ Th1 et Th2 dans la réaction de rejet sont controversées. Alors que le rôle des cellules Th1 dans la pathogénèse du rejet est bien établi, l'hypothèse que les cellules Th2 favorisent l'acceptation de la greffe est invalide puisque ces cellules sont capables de déclencher des voies alternatives de rejet. En effet, la fonction effectrice des lymphocytes Th2 a été démontrée dans beaucoup de modèles de rejet de greffe ou de tumeur, et dans la maladie du greffon contre l'hôte. Les caractéristiques principales du rejet de type Th2 sont sa dépendance envers la production d'IL-4 et d'IL-5, le recrutement d'éosinophiles au site du rejet, et son inhibition par les lymphocytes T CD8+ alloréactifs. Les éosinophiles activés exercent leur activité cytotoxique par la libération de plusieurs molécules cytotoxiques comme l’EDN, l’ECP, la MBP et l’EPO. Ces molécules sont probablement responsables de la capacité des éosinophies à affecter la perméabilité vasculaire et à induire des dégâts tissulaires dans les organes rejetés.

L'interleukine 9 (IL-9) est une cytokine produite par les lymphocytes T qui joue un rôle important dans les voies effectrices Th2. Dans la littérature, l’IL-9 est fortement associée au développement de l’éosinophilie tissulaire. Dans notre première étude, nous avons analysé le rôle joué par l'IL-9 dans le rejet d'allogreffe bm12 par des souris B6 (pour C57BL/6), un modèle dans le lequel une simple disparité au niveau de la molécule du CMH de classe II favorise une réaction inflammatoire de type Th2. Dans ce modèle, de faible alloantigénicité, les greffes cardiaques bm12 survivent presque indéfiniment dans les receveurs B6 (>60 jours). Nos expériences ont été conçues afin de savoir si l’expression de l’IL-9 au niveau de la greffe pouvait modifier la survie de greffes cardiaques exprimant les alloantigènes bm12. Nous avons ainsi montré que la production locale d’IL-9 induit le rejet des allogreffes cardiaques exprimant l’alloantigène I-Abm12 (survie <30jours). Aucun des organes transgéniques pour l’IL-9 n’a survécu plus de 30 jours alors que des greffes non transgéniques ne furent pas rejetées (>50 jours). L’analyse histologique des allogreffes cardiaques transgéniques pour l’IL-9 montre une infiltration cellulaire dense du myocarde. La composante principale de cet infiltrat est la présence de nombreux éosinophiles.

Pour étudier la contribution des cytokines de type Th2, comme l’IL-4 et l’IL-5, dans le rejet des cœurs transgéniques pour l’IL-9, nous avons sélectivement bloqué ces cytokines lors du processus de rejet. Le traitement avec des anticorps neutralisant l’IL-4 bloque complètement le rejet induit par l’IL-9 et permet la survie à long terme des allogreffes cardiaques. Au point de vue de l’histologie ces greffes ne montrent ni infiltration leucocytaire ni artériopathie. Afin de déterminer si l’infiltration éosinophilique induite par l’IL-9 provient de l’activité directe de l’IL-9 ou est le résultat de la sécrétion d’IL-5, un traitement avec un anticorps anti-IL-5 a été appliqué aux receveurs d'allogreffe cardiaque. Ce traitement augmente la survie de la majorité des allogreffes et modifie de manière marquée la composition de l’infiltrat cellulaire en prévenant le recrutement des éosinophiles. De manière intéressante, les cœurs transgéniques pour l’IL-9 qui survivent indéfiniment après le traitement anti-IL-5 arborent une importante fibrose.

A la différence du cœur bm12, la peau bm12 greffée sur un receveur B6 subit un rejet rapide et l'histologie des greffes rejetées révèle la présence d'infiltrats denses à éosinophiles. Notre laboratoire a montré que ce processus de rejet est dirigé par les lymphocytes T CD4+ alloréactifs et que les souris B6 déficientes pour l'IL-5 et la voie de cytotoxicité Fas/Fas-L sont incapables de rejeter des peaux bm12. Nos premiers résultats laissaient supposer un rôle pour l'IL-9 dans notre modèle de rejet de greffes en disparité des molécules du CMH de classe II: premièrement, nous avions observé la production d'IL-9 par les lymphocytes T de type Th2 alloréactifs et deuxièmement, l'ARNm d'IL-9 était fortement exprimé au niveau des allogreffes de peaux rejetées. C’est pourquoi, la survie de peaux bm12, déficientes pour la molécule Fas, greffées sur des receveurs B6 déficients pour l'IL-9 (B6.IL-9-/-) a été comparée avec celle de peaux transplantées sur des receveurs B6. Nous avons montré que, comme les souris B6 normales, les animaux B6.IL-9-/- rejettent leur greffe dans les 15 jours. Donc, contrairement à l'IL-5, l'IL-9 n'est pas essentielle pour le rejet de peau dirigé par les cellules T CD4+ de type Th2 dans notre modèle de disparité des molécules du CMH de classe II.

Néanmoins, les allogreffes de peaux, dans notre modèle de disparité des molécules du CMH de classe II, contiennent moins d’éosinophiles lorsqu’elles sont rejetées par des receveurs déficients pour la synthèse d’IL-9 (IL-9-/-). En plus du modèle bm12, nous avons également observé un rôle de l’IL-9 dans un autre modèle de rejet Th2. Il a été montré par notre laboratoire que le rejet d’allogreffes cardiaques Balb/c complètement incompatibles par des souris receveuses B6.CD8-/- est caractérisé par le recrutement d’éosinophiles dans l’organe rejeté (106). Dans celui-ci, l’ARNm de l’IL-9 est présent pendant le rejet, de même que l’IL-4 et l’IL-5 et les greffes rejetées par des receveurs IL-9-/- contiennent moins d’éosinophiles par rapport à des receveurs contrôles. Les mécanismes par lesquels l’IL-9 induit le recrutement des éosinophiles ne sont pas complètement connus.

L’IL-5 est considérée comme la cytokine clé pour le développement de l’éosinophilie. De plus, le rejet aigu des cœurs transgéniques pour l’IL-9 est caractérisé par une infiltration massive d'éosinophiles et est inhibé lors de la neutralisation de l'IL-5. Nous avons entrepris la seconde étude pour investiguer le lien fonctionnel entre l’IL-9 et l’IL-5 dans le rejet d’allogreffe, ce qui permettra de mieux comprendre le recrutement des éosinophiles par l’IL-9.

Bien que le rejet ne soit pas inhibé par le manque d’IL-9, les allogreffes rejetées par les souris déficientes en IL-9 contiennent moins d’éosinophiles par rapport à des souris contrôles et présentent une production plus faible d’IL-5 par les cellules T alloréactives. De manière intéressante, la production optimale d’IL-5 après une stimulation allogénique requiert un récepteur à l’IL-9 (IL-9R) fonctionnel sur les cellules répondeuses. De plus, l’infiltration d’éosinophiles induite par l’IL-9 est absente dans des peaux transplantées sur des receveurs déficients pour le récepteur de l’IL-9. Finalement, la production d’IL-5 par des cellules T CD4+ stimulées par l’anti-CD3 est abolie par la neutralisation de l’IL-9.

En conclusion, nous pouvons dire que l'IL-9 est capable d'induire un rejet de type Th2, caractérisé par une forte infiltration d’éosinophiles et une dépendance à l'IL-5 et à l'IL-4. Notre étude montre également que l’IL-9 peut agir directement sur les cellules T CD4+ pour induire leur capacité à sécréter de l’IL-5. Cependant, l’IL-9 n’est pas indispensable au processus de rejet Th2 et il est probable que lorsque l’IL-9 est bloquée d'autres cytokines soient capables de compenser son absence. Notre étude permet une meilleure compréhension des voies complexes du recrutement des éosinophiles.


Doctorat en sciences biomédicales
info:eu-repo/semantics/nonPublished

APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the bibliographies on the topic 'Transplantation of organs, tissues, etc. in children' for other source types:
Journal articles Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography